Helge Lehmann, MD
Clinical Cardiac Electrophysiology · Salt Lake City, UTNPI 1871955328
Payments from drug & device makers
What this record shows
This record is dominated by grants: $44,934 of the $48,749 with a category attached, or 92.2%. Medtronic accounts for 71.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $24,934 and has fallen 99.3% since, to $171 in 2025.
Across 31 payments — averaging $1572.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$35K
- Boston Scientific$13K
- Abbott$1K
- Astellas Pharma US Inc$99
- Biosense Webster, Inc.$35
What the payments were for
- Grants$44,93492%
- Travel & lodging$2,3725%
- Food & beverage$1,3443%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 17 | $34,699 |
| Boston Scientific | 4 | $12,644 |
| Abbott | 8 | $1,271 |
| Astellas Pharma US Inc | 1 | $99 |
| Biosense Webster, Inc. | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$7,622
- Micra$1,888
- AVEIR$1,135
How this compares
$48,749 in reported general payments places this provider in the 65th percentile of 29 clinical cardiac electrophysiology providers in Utah.
See all clinical cardiac electrophysiology providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $22,378 |
| Metoprolol Succinate | 26 | $194 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Salt Lake City
- Ravi RanjanSalt Lake City$345K
- John DaySalt Lake City$313K
- Roger FreedmanSalt Lake City$177K
- Nischala NannapaneniSalt Lake City$57K
- Richard SheltonSalt Lake City$47K
- Anish ShahSalt Lake City$43K
- Qussay MarashlySalt Lake City$34K
- Michael CrawfordSalt Lake City$30K
- Jared MillerSalt Lake City$8K
- Travis WallSalt Lake City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.